Angela Santoni
Santoni, Angela
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 305693777 (Personal)
Permalink: http://viaf.org/viaf/305693777
Preferred Forms
-
100 0 _
‡a
Angela Santoni
-
100 1 _
‡a
Santoni , Angela
-
100 1 _ ‡a Santoni, Angela
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| Embryo implantation : from basics to clinics |
|
| The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma |
|
| "Immuno-Transient Receptor Potential Ion Channels": The Role in Monocyte- and Macrophage-Mediated Inflammatory Responses. |
|
| In vitro and in vivo models to study chemokine regulation of angiogenesis |
|
| Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis. |
|
| Inflammatory and immune reactions in response to chemotherapy-induced cell death. Viral mimicry chemotherapy : ds RNA sensors and IFNAR signalling indispensable for immunogenic tumor cell death |
|
| Inhibition of glycogen synthase kinase-3 increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of STAT3. |
|
| Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. |
|
| Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells. |
|
| Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. |
|
| Involvement of the TRPML Mucolipin Channels in Viral Infections and Anti-viral Innate Immune Responses |
|
| JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians |
|
| Key role of proline-rich tyrosine kinase 2 in interleukin-8 (CXCL8/IL-8)-mediated human neutrophil chemotaxis. |
|
| Kinetics of in vivo proliferation and death of memory and naive CD8 T cells: parameter estimation based on 5-bromo-2'-deoxyuridine incorporation in spleen, lymph nodes, and bone marrow |
|
| Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer |
|
| Mandatory vaccination in Italy: Time for engagement of immunologists |
|
| Memory NK Cell Features Exploitable in Anticancer Immunotherapy |
|
| Memory T-cell competition for bone marrow seeding |
|
| MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma. |
|
| Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA-associated vasculitis. |
|
| The multifaceted role of PIP2 in leukocyte biology. |
|
| Multiple levels of chemokine receptor regulation in the control of mouse natural killer cell development |
|
| The natural killer cell and its interaction with immune and non-immune cells : second meeting of the Society for Natural Immunity, Taormina, Italy, May 25-28, 1994 : abstracts |
|
| Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells |
|
| Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis |
|
| Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions. |
|
| Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells |
|
| NCR+ ILC3 maintain larger STAT4 reservoir via T-BET to regulate type 1 features upon IL-23 stimulation in mice |
|
| Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes |
|
| Negative regulation of innate lymphoid cell responses in inflammation and cancer |
|
| Negative signals from FcepsilonRI engagement attenuate mast cell functions. |
|
| Neutrophil diversity and plasticity in tumour progression and therapy |
|
| New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer |
|
| Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation. |
|
| NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease. |
|
| NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma |
|
| NKG2D and Its Ligands: "One for All, All for One". |
|
| NKG2D/Ligand dysregulation and functional alteration of innate immunity cell populations in pediatric IBD |
|
| NKG2D Ligand Shedding in Response to Stress: Role of ADAM10 |
|
| Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. |
|
| Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production |
|
| An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation |
|
| Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression. |
|
| Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. |
|
| p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. |
|
| p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells. |
|
| Peripheral and intestinal CD4+ T cells with a regulatory phenotype in pediatric patients with inflammatory bowel disease. |
|
| PIP2-dependent regulation of Munc13-4 endocytic recycling: impact on the cytolytic secretory pathway |
|
| Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients |
|
| Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention |
|
| The POU-Domain Transcription Factor Oct-6/POU3F1 as a Regulator of Cellular Response to Genotoxic Stress |
|
| Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration |
|
| Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors |
|
| Réactions inflammatoires et immunitaires en réponse à la mort cellulaire induite par la chimiothérapie. Mimétisme viral par la chimiothérapie : rôle des récepteurs à l’ARN double brin et de la signalisation par l’IFNAR dans l’immunogénicité de la mort tumorale. |
|
| Reactive oxygen species- and DNA damage response-dependent NK cell activating ligand upregulation occurs at transcriptional levels and requires the transcriptional factor E2F1. |
|
| Reconstitution of multifunctional CD56lowCD16low natural killer cell subset in children with acute leukemia given α/β T cell-depleted HLA-haploidentical haematopoietic stem cell transplantation. |
|
| Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy |
|
| Regulation and trafficking of the HLA-E molecules during monocyte-macrophage differentiation |
|
| Regulation of PD-L1 Expression by NF-κB in Cancer |
|
| Role of Distinct Natural Killer Cell Subsets in Anticancer Response |
|
| SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity |
|
| The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases |
|
| Senescent cells: Living or dying is a matter of NK cells |
|
| SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells |
|
| Syk-dependent regulation of Hrs phosphorylation and ubiquitination upon FcεRI engagement: impact on Hrs membrane/cytosol localization |
|
| Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells |
|
| Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy. |
|
| Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors |
|
| Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK Cells |
|
| Translating the anti-myeloma activity of Natural Killer cells into clinical application |
|
| Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients |
|
| Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer |
|
| Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming. |
|
| Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells. |
|
| The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing |
|
| Ubiquitination and endocytosis of the high affinity receptor for IgE. |
|
| The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses |
|
| Uterine NK cell development, migration and function |
|
| Vaccines: An achievement of civilization, a human right, our health insurance for the future |
|
| The yin-yang of the interaction between myelomonocytic cells and NK cells |
|
